CELL THERAPEUTICS, INC.

AP3ANA LIFESCIENCES

AP THREE ANA APANA APEANA LIFE SCIENCES;LIFESCIENCES;Medical and scientific research in the fields of predictive health profiling, genomics, bioinformatics, and pharmacogenomics to guide clinical trials and treatments; Conducting clinical trials; Pharmaceutical and pharmacogenomic research, development, and testing; none of the foregoing in the field of opiates and analgesics;

APANA GENOMICS

GENOMICS;Medical and scientific research in the fields of predictive health profiling, genomics, bioinformatics, and pharmacogenomics to guide clinical trials and treatments; Conducting clinical trials; Pharmaceutical and pharmacogenomic research, development, and testing; none of the foregoing in the field of opiates and analgesics;

APANA LIFESCIENCES

APANA LIFE SCIENCES;LIFESCIENCES;Medical and scientific research in the fields of predictive health profiling, genomics, bioinformatics, and pharmacogenomics to guide clinical trials and treatments; Conducting clinical trials; Pharmaceutical and pharmacogenomic research, development, and testing; none of the foregoing in the field of opiates and analgesics;

AROZAXI

Pharmaceutical preparations, drugs and agents used for the treatment of cancer; pharmaceutical preparations used for the treatment of immunological and inflammatory diseases; chemotherapy agents; and antibiotics;

AZABILT

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of immunological and inflammatory diseases and for use in chemotherapy treatment; and pharmaceutical preparations used for the treatment of cancer;

CANCER CARE SOLUTIONS

Educational services, namely, conducting classes, seminars, conferences and workshops in the field of cancer, cancer treatment, and cancer research; and distributing written and audio/visual course materials in connection therewith;Pharmaceuticals used in the treatment of cancers, infections secondary to the oncologic disease, and the management of pain accompanying either the disease process or the associated treatment regimens;CANCER CARE;Laboratory research and development services in the field of pharmaceutical products; and providing information in the field of health, medicine, and pharmaceutical products;

CELL THERAPEUTICS, INC.

pharmaceutical preparations, namely, bio-chemical signaling pathway modulators of a non-living nature, for use in all fields of medicine, medical research, and pharmacology;INC.;

CELL THERAPEUTICS, INC.

INC.;laboratory research and developmental services in the field of biochemical and therapeutic products that affect cellular signaling pathways;

CHIRX

laboratory research, analysis and testing services for others, in the nature of screening chemical compounds for therapeutic activity;

CTI

synthesis of non-living compounds that affect cellular signaling pathways to the order and specification of others, for use in medical applications;laboratory research and developmental services in the field of non-living biochemical and therapeutic products that affect cellular signaling pathways;

CTI

pharmaceutical preparations, namely, cell signaling pathway modulators of a non-living nature, for use in all fields of medicine, medical research, and pharmacology;

CTI

laboratory research and developmental services in the field of biochemical and therapeutic products that affect cellular signaling pathways;

CTI

Pharmaceutical preparations, namely cell signaling pathway modulators of a non-living nature, for use in all fields of medicine, medical research, and pharmacology; and pharmaceutical preparations used for the treatment of cancer, immunological and inflammatory diseases, infections secondary to the oncologic disease, and the management of pain accompanying either the disease process or the associated treatment regimens;

CTI

Pharmaceutical preparations used for the treatment of cancer; and pharmaceutical preparations used for the treatment of immunological and inflammatory diseases, infections secondary to the oncologic disease, and the management of pain accompanying either the disease process or the associated treatment regimens;CELL THERAPEUTICS INCORPORATED;

CTI

Pharmaceutical, medical and laboratory research services in the field of pharmaceuticals, cancer, genetic disorders and gene therapy; providing information in the field of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy; providing an online magazine in the fields of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy; and consultation related to the foregoing;

CTI DISCOVERY TREATMENT RECOVERY

pharmaceutical preparations, namely, cell signaling pathway modulators of a non-living nature, for use in all fields of medicine, medical research, and pharmacology;TREATMENT or RECOVERY;

CTI DISCOVERY TREATMENT RECOVERY

DISCOVERY, TREATMENT or RECOVERY;laboratory research and developmental services in the field of biochemical and therapeutic products that affect cellular signaling pathways;

CTI DISCOVERY TREATMENT RECOVERY

pharmaceutical preparations, namely, cell signaling pathway modulators of a non-living nature, for use in all fields of medicine, medical research, and pharmacology;TREATMENT or RECOVERY;

CTI DISCOVERY TREATMENT RECOVERY

DISCOVERY, TREATMENT or RECOVERY;laboratory research and developmental services in the field of biochemical and therapeutic products that affect cellular signaling pathways;

CTI MAKING CANCER MORE TREATABLE

pharmaceutical, medical and laboratory research services in the field of pharmaceuticals, cancer, genetic disorders and gene therapy; providing information in the field of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy; providing an online magazine in the fields of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy; and consultation related to the foregoing;

LSF

pharmaceutical preparations for use in the treatment of cancer, immunological and inflammatory diseases;

ONCOLOGISTS 6TH VITAL SIGN

ONCOLOGISTS SIXTH VITAL SIGN;ONCOLOGISTS;Research and development of pharmaceutical preparations; product research and development for others in the field of pharmaceutical preparations; product research and development services, namely, assessing intended target recipients of pharmaceutical preparations and positioning pharmaceutical preparations for success in clinical development and commercial use; and providing technical consultation in the field of pharmaceutical product research and development;

OPAXCIO

Pharmaceutical preparations, drugs and agents used for the treatment of cancer; pharmaceutical preparations used for the treatment of immunological and inflammatory diseases; chemotherapy agents; and antibiotics;

PATHWAY

research and development of new products for others in the medical and pharmaceutical industries;

PATHWAY

research and development of new products for others in the medical and pharmaceutical industries;

PIXOLTI

Pharmaceutical preparations for the treatment of immunological and inflammatory diseases and for use in chemotherapy treatment; pharmaceutical preparations used for the treatment of cancer;

PIXOLTI PIXANTRONE DIMALEATE

The mark consists of the wording Pixolti pixantrone dimaleate positioned to the left of a stylized flame design.;Pharmaceutical preparations for the treatment of immunological and inflammatory diseases and for use in chemotherapy treatment; pharmaceutical preparations used for the treatment of cancer;Color is not claimed as a feature of the mark.;PIXANTRONE DIMALEATE;